P5 Health Ventures

Genialis, Inc. is a computational precision medicine company that specializes in the development of a web-based software platform for biological data management, analysis, visualization, and interpretation. Founded in 2011 and based in Houston, Texas, the company focuses on unraveling complex biology to discover actionable biomarkers that can enhance disease treatment. Its platform combines a range of visual analytics and bioinformatics tools, facilitating the storage and tracking of data while automating primary analyses to ensure reproducibility. Genialis enables non-experts to access sophisticated downstream analyses and supports secure sharing of data insights. The company's efforts aim to assist pharmaceutical and diagnostics companies in developing more effective drugs and deploying tests that improve treatment decisions, thereby increasing the probability of clinical success and validating therapeutic targets.

Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Hawthorne Effect facilitates accessible clinical trials worldwide. It employs a Visit Management System that respects sponsor-investigator relationships, promotes shared technology for protocol compliance, and deploys trained healthcare providers ('HEROs') for patient visits anytime, anywhere, minimizing 'lost to follow-up' cases.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Iterative Scopes, Inc. is a Boston-based company established in 2017 that specializes in developing machine learning-powered diagnostic tools aimed at assisting gastroenterologists in the prevention of colon cancer. The company focuses on providing innovative solutions for physicians and life sciences professionals within the colorectal cancer and inflammatory bowel disease sectors. By leveraging advanced technology, Iterative Scopes aims to enhance diagnostic accuracy and improve patient outcomes in these critical areas of healthcare.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Babyscripts is a health technology company that provides a virtual maternity care platform for prenatal and postpartum management. The platform combines a mobile education layer with gestational-age content and resources through one year postpartum, remote monitoring using connected medical devices, and a collaboration with payers to improve care coordination and reduce costs. This three-tier approach enables clinicians to manage pregnancies outside the clinic, monitor risk factors remotely, and intervene promptly when needed, while expanding access and automating routine elements of care to support better outcomes for mothers and infants.

Cohero Health, Inc. is a digital respiratory health company that focuses on developing solutions for the management of asthma and chronic obstructive pulmonary disease. The firm offers a connected health platform that includes the BreatheSmart app, which provides personalized reminders for medication adherence, tracks inhaler usage, measures lung function, and monitors symptoms and environmental conditions. Cohero Health also supplies mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker for both control and rescue medications. Additionally, the company offers BreatheSmart Connect, a Software-as-a-Service solution that facilitates remote monitoring and communication between patients and healthcare providers. Founded in 2012 and headquartered in New York, Cohero Health operates as a subsidiary of AptarGroup, Inc.